TY - JOUR
T1 - The "dying-back" phenomenon of motor neurons in ALS
AU - Dadon-Nachum, Michal
AU - Melamed, Eldad
AU - Offen, Daniel
N1 - Funding Information:
Acknowledgments This work was performed by Michal Dadon in partial fulfillment of the requirements for a Ph.D. degree. This work was supported, in part, by The Devora Eleonora Kirshman Fund for Research of Parkinson’s Disease, Tel Aviv University and by the Norma and Alan Aufzein Chair of Research of Parkinson’s Disease.
PY - 2011/3
Y1 - 2011/3
N2 - Amyotrophic lateral sclerosis (ALS) is a lethal disease, characterized by progressive death of motor neurons with unknown etiology. Evidence from animal models indicates that neuronal dysfunction precedes the clinical phase of the disease. However, in parallel extensive nerve sprouting and synaptic remodeling as part of a compensatory reinnervation processes and possibly also of motor neurons pathology was demonstrated. Therefore, the weakness in muscle groups will not be clinically apparent until a large proportion of motor units are lost. This motor unit loss and associated muscle function which precedes the death of motor neurons may resemble the "die-back" phenomena. Studies indicated that in the early stages the nerve terminals and motor neuron junctions are partially degraded while the cell bodies in the spinal cord are mostly intact. Treatments to rescue motor neurons according to "dying-forward" model of motor neuron pathology in ALS have shown only limited success in SOD1G93A transgenic mice as well as in humans. If cell body degeneration is late compared with axonal degeneration, early intervention could potentially prevent loss of motor neurons. Therefore, it should be considered, according to the dying back hypothesis, to focus on motor neurons terminals in order to delay or prevent the progressive degradation.
AB - Amyotrophic lateral sclerosis (ALS) is a lethal disease, characterized by progressive death of motor neurons with unknown etiology. Evidence from animal models indicates that neuronal dysfunction precedes the clinical phase of the disease. However, in parallel extensive nerve sprouting and synaptic remodeling as part of a compensatory reinnervation processes and possibly also of motor neurons pathology was demonstrated. Therefore, the weakness in muscle groups will not be clinically apparent until a large proportion of motor units are lost. This motor unit loss and associated muscle function which precedes the death of motor neurons may resemble the "die-back" phenomena. Studies indicated that in the early stages the nerve terminals and motor neuron junctions are partially degraded while the cell bodies in the spinal cord are mostly intact. Treatments to rescue motor neurons according to "dying-forward" model of motor neuron pathology in ALS have shown only limited success in SOD1G93A transgenic mice as well as in humans. If cell body degeneration is late compared with axonal degeneration, early intervention could potentially prevent loss of motor neurons. Therefore, it should be considered, according to the dying back hypothesis, to focus on motor neurons terminals in order to delay or prevent the progressive degradation.
KW - Amyotrophic lateral sclerosis
KW - Dying back
KW - Motor neuron
UR - http://www.scopus.com/inward/record.url?scp=79955824241&partnerID=8YFLogxK
U2 - 10.1007/s12031-010-9467-1
DO - 10.1007/s12031-010-9467-1
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 21057983
AN - SCOPUS:79955824241
SN - 0895-8696
VL - 43
SP - 470
EP - 477
JO - Journal of Molecular Neuroscience
JF - Journal of Molecular Neuroscience
IS - 3
ER -